Filing Details

Accession Number:
0000883984-13-000058
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-11-04 11:30:18
Reporting Period:
2013-11-01
Filing Date:
2013-11-04
Accepted Time:
2013-11-04 11:30:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
883984 Icu Medical Inc ICUI Surgical & Medical Instruments & Apparatus (3841) 330022692
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1073401 A Richard Costello 951 Calle Amanecer
San Clemente CA 92673
Vice President Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-11-01 6,116 $43.62 10,823 No 4 X Direct
Common Stock Acquisiton 2013-11-01 10,000 $43.12 20,823 No 4 X Direct
Common Stock Disposition 2013-11-01 20,538 $61.00 285 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-01 10,000 $0.00 10,000 $43.12
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-11-01 6,116 $0.00 6,116 $43.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2021-02-02 No 4 X Direct
8,884 2021-07-20 No 4 X Direct
Footnotes
  1. The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.70 to $61.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  2. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
  3. Transaction is the exercise of a derivative security; see Column 2.